Inge Tanja has a diverse background in research and regulatory affairs within the pharmaceutical and biotechnology sectors. They served as Head of the ICF team at IQVIA in 2024, and previously held roles including Contracted Study Start-up Specialist at Eli Lilly and Company and InHouse CRA at ICON plc. Inge's earlier experience includes significant contributions as a Senior Research Technician at the KIT (Royal Tropical Institute), where they focused on study execution and quality systems implementation. Inge earned a Bachelor’s Degree from Amsterdam University of Applied Sciences and has completed several certifications in GCP, GCLP, and GLP.
This person is not in the org chart
This person is not in any teams
This person is not in any offices